论文部分内容阅读
笔者对30例充血性心力衰竭患者,在传统强心、利尿治疗基础上,加用血管紧张素转换酶抑制剂卡托普利的临床疗效进行分析,现报道如下。病例选择:30例均为住院患者,常规强心、利尿治疗无效加用卡托普利。其中男12例,女18例,年龄34～78岁,平均57.5岁。风心病6例,扩张型心肌病5例,肺心病5例,冠心病14例。心功能Ⅳ级21例,Ⅲ级6例,Ⅱ级3例。治疗方法:经常规强心、利尿治疗一周无效后加用卡托普利。开始剂量:12.5mg,一日三次口服,如无明显副作用则渐增
The author of 30 patients with congestive heart failure, in the traditional cardioplegia, diuretic therapy based on the use of angiotensin-converting enzyme inhibitor captopril clinical efficacy analysis are reported below. Case selection: 30 cases were hospitalized patients, conventional cardiac, diuretic treatment plus captopril ineffective. Including 12 males and 18 females, aged 34 to 78 years old, with an average of 57.5 years old. 6 cases of rheumatic heart disease, 5 cases of dilated cardiomyopathy, 5 cases of cor pulmonale and 14 cases of coronary heart disease. 21 cases of grade Ⅳ, 6 cases of grade Ⅲ and 3 cases of grade Ⅱ. Treatment: Conventional cardiac, diuretic treatment plus captopril after a week invalid. Start dose: 12.5mg, orally three times a day, if no significant side effects are increasing